Show results for
Refine by
Protein Expression Suppliers Serving Burundi
118 companies found
based inAnn Arbor, MICHIGAN (USA)
Headquartered in Ann Arbor, Michigan, Cayman Chemical Company supplies scientists worldwide with the resources necessary for advancing human and animal health. We manufacture high quality biochemicals, assay kits, antibodies, and recombinant ...
based inWoburn, MASSACHUSETTS (USA)
We are an investigational-stage infectious disease company focused on combating all diseases resulting from herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) infections. Using our proprietary technology, we are developing rationally ...
One of the most celebrated achievements of modern medicine is the eradication of the smallpox virus with the use of a live-attenuated vaccine. We are advancing the applied science of attenuating live viruses to develop an entirely new class of ...
based inGuildford, UNITED KINGDOM
MR Solutions is at the forefront of MRI technology, particularly in the domain of cryogen-free superconducting MRI systems. Their innovations range from 3T to 9.4T, featuring dry magnets that eliminate the need for liquid helium, which not only ...
MR Solutions offers a specialized upgrade kit designed to revitalize orphaned or outdated preclinical MRI systems, particularly those previously supplied by other manufacturers like Agilent. Leveraging over three decades of expertise in magnetic ...
based inWashington, DISTRICT OF COLUMBIA (USA)
TriStar is a Maryland LLC founded in 2003 with a business office in Washington DC. Our manufacturing, IHC and Molecular Lab is in Catania (Italy) and collaborating Medical institutes in Germany, Italy, UK & France TriStar has pioneered the use of ...
based inWichita, KANSAS (USA)
Neotherma Oncology is led by experienced healthcare executives who are working toward the dream of more effective treatments for cancer. NeoTherma Oncology is developing a groundbreaking type of radio frequency (RF) thermal treatment for deep solid ...
NeoTherma Oncology is a clinical stage medical device company developing a proprietary Thermal Treatment (VectRx) system for deep solid tumors. Our technology is based on applying a safe, non-invasive, non-ionizing electromagnetic field to produce ...
based inSan Jose, CALIFORNIA (USA)
Founded in 2005 and headquartered in San Jose, California, Advansta accelerates life science research by developing and supplying novel protein characterization tools that offer superior performance, simplicity, and convenience. Advansta’s mission ...
In December of 2019, the SARS-CoV-2 virus, which causes the disease COVID-19, was first detected in Wuhan, China. The SARS-CoV-2 virus is a single-stranded RNA coronavirus that causes respiratory infections. The rapid spread of COVID-19 has resulted ...
based inSan Diego, CALIFORNIA (USA)
Aviva Systems Biology provides our customers with an extensive collection of quality antibodies for research and diagnostic applications. Aviva currently offers antibodies to more than 7,000 different protein targets due to our high throughput ...
Aviva provides customized solutions to each protein expression project. Our expert scientific staff has experience with difficult proteins and have produced more than 2,500 recombinant ...
based inYokohama, JAPAN
We provide a unique combination of services and products to power your translational research. With scientists and laboratories on three continents, REPROCELL has the scientific and clinical expertise to better translate your discoveries into ...
Encodes the human Oct4 protein. Stemgent Oct4 mRNA encodes the Oct4 protein commonly used in cellular reprogramming systems for the generation of induced pluripotent stem (iPS) cells. This in vitro transcribed mRNA incorporates both pseudouridine ...
based inNanjing, CHINA
PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) is a leading provider of innovative chemistry products and services throughout the pharmaceutical R&D process and commercial production. Its core businesses include a rationally designed building ...
based inOxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
The Modi-2 vaccine exploits a second post-translational modification, stimulating the production of CD4 T cells using tumour-associated peptide epitopes in which the lysine residues are converted to homocitrulline. This change occurs via a process ...
based inUppsala, SWEDEN
Abera Bioscience is a platform and vaccine development company based on over 30 years of research in the medical, molecular and microbiological field. Abera was founded in 2012 as a spin-out from the Swedish protein production company Xbrane ...
based inTokyo, JAPAN
Healios will expand the possibilities for curing diseases to increase and further enrich quality of life through the development and supply of regenerative medicine products as part of the rapid progress of regenerative medicine taking place in the ...
A universal donor cell is a kind of cell that can be used for transplantation into anyone. In other words, it is a cell in which the induction of immune rejection*１ (Human Leukocyte ...
based inWaltham, MASSACHUSETTS (USA)
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are ...
The Applied Biosystems QuantStudio 7 Pro Real-Time PCR System adds innovative smart features to the real-time PCR (qPCR) workflow, all in a compact footprint. With facial authentication, voice commands, Smart Help, multiplex capability, motorized ...
based inNedlands, Perth, AUSTRALIA
Proteomics International is a pioneering medical technology company operating at the forefront of predictive diagnostics and bio-analytical services. The Company specialises in the area of proteomics – the industrial scale study of the structure and ...
based inFrederick, MARYLAND (USA)
RoosterBio, Inc. is radically simplifying the use of adult human mesenchymal stem/stromal cells (hMSCs) to propel the commercialization of regenerative technologies. RoosterBio is enabling living cellular technologies to become more affordable, ...
Exosomes / Extracellular Vesicles (EVs) are an emerging class of biologics that play a crucial role in intercellular communication and hold tremendous promise for therapeutic and diagnostic use. A key challenge in the clinical translation of ...
based inFremont, CALIFORNIA (USA)
Ultima Genomics is a pioneering company in the genomics sector, focusing on revolutionizing genomic sequencing through innovative technology and new sequencing architecture. The company's mission is to expand the scale of omics information, thereby ...
based inDiepenbeek, BELGIUM
Founded in 2012, InnoSer is an innovative and dynamic contract research organization supporting preclinical development of drugs from its facilities in Belgium and the Netherlands. InnoSer supports its customers in the critical steps of their drug ...
We offer multi-validation solutions for preclinical targets across numerous therapeutic fields. ...
based inGöttingen, GERMANY
IBA GmbH is a biotechnology company providing products for life science research in academia and industry. We develop high performance research tools for cell and protein isolation based on our proprietary Strep-tag technology. Situated in ...
based in
Tectonic Therapeutic, Inc., a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs, announced merger with AVROBIO, Inc. The combined company will ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
TP-1287 is an investigational oral CDK9 inhibitor that has shown favorable oral bioavailability in preclinical models. TP-1287 is enzymatically cleaved, yielding the active moiety, a potent inhibitor of CDK9.35 Inhibiting CDK9 is thought to ...